14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $141.16 $183.01 Friday, 3rd May 2024 APTO stock ended at $1.20. This is 0.84% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 3.36% from a day low at $1.19 to a day high of $1.23.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Aptose Biosciences prices

Date Open High Low Close Volume
Feb 22, 2023 $0.640 $0.678 $0.616 $0.635 103 813
Feb 21, 2023 $0.695 $0.700 $0.621 $0.650 192 829
Feb 17, 2023 $0.693 $0.695 $0.672 $0.674 64 110
Feb 16, 2023 $0.680 $0.695 $0.660 $0.695 106 372
Feb 15, 2023 $0.655 $0.700 $0.650 $0.680 120 729
Feb 14, 2023 $0.670 $0.700 $0.651 $0.670 68 684
Feb 13, 2023 $0.700 $0.745 $0.663 $0.680 131 553
Feb 10, 2023 $0.710 $0.710 $0.670 $0.700 91 008
Feb 09, 2023 $0.700 $0.710 $0.665 $0.690 169 498
Feb 08, 2023 $0.750 $0.750 $0.690 $0.697 173 202
Feb 07, 2023 $0.740 $0.759 $0.714 $0.727 174 372
Feb 06, 2023 $0.760 $0.770 $0.724 $0.749 119 389
Feb 03, 2023 $0.720 $0.770 $0.720 $0.756 268 659
Feb 02, 2023 $0.750 $0.760 $0.720 $0.740 269 610
Feb 01, 2023 $0.755 $0.767 $0.730 $0.750 238 804
Jan 31, 2023 $0.746 $0.760 $0.740 $0.750 368 295
Jan 30, 2023 $0.750 $0.750 $0.715 $0.741 694 291
Jan 27, 2023 $0.710 $0.760 $0.700 $0.760 367 445
Jan 26, 2023 $0.700 $0.720 $0.700 $0.710 150 644
Jan 25, 2023 $0.700 $0.720 $0.690 $0.705 247 984
Jan 24, 2023 $0.700 $0.710 $0.680 $0.700 326 207
Jan 23, 2023 $0.700 $0.700 $0.671 $0.690 165 470
Jan 20, 2023 $0.663 $0.680 $0.650 $0.680 86 323
Jan 19, 2023 $0.674 $0.674 $0.631 $0.651 197 047
Jan 18, 2023 $0.680 $0.700 $0.630 $0.660 238 100
Click to get the best stock tips daily for free!

About Aptose Biosciences

Aptose Biosciences Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Ph... APTO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT